Correlation Between Pharmala Biotech and Aridis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Pharmala Biotech and Aridis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmala Biotech and Aridis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmala Biotech Holdings and Aridis Pharmaceuticals, you can compare the effects of market volatilities on Pharmala Biotech and Aridis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmala Biotech with a short position of Aridis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmala Biotech and Aridis Pharmaceuticals.

Diversification Opportunities for Pharmala Biotech and Aridis Pharmaceuticals

0.0

Correlation Coefficient

Pharmala Biotech  Aridis Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Pharmala and Aridis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmala Biotech Holdings and Aridis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aridis Pharmaceuticals and Pharmala Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmala Biotech Holdings are associated (or correlated) with Aridis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aridis Pharmaceuticals has no effect on the direction of Pharmala Biotech i.e., Pharmala Biotech and Aridis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pharmala Biotech and Aridis Pharmaceuticals

If you would invest (100.00) in Aridis Pharmaceuticals on December 2, 2024 and sell it today you would earn a total of  100.00  from holding Aridis Pharmaceuticals or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pharmala Biotech Holdings  vs.  Aridis Pharmaceuticals

Pharmala Biotech Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Aridis Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aridis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Aridis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Pharmala Biotech and Aridis Pharmaceuticals

The main advantage of trading using opposite Pharmala Biotech and Aridis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmala Biotech position performs unexpectedly, Aridis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aridis Pharmaceuticals will offset losses from the drop in Aridis Pharmaceuticals' long position.

The idea behind Pharmala Biotech Holdings and Aridis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..